5,897 results match your criteria Imaging in Mitral Stenosis

Transient ischemic attack due to multiple spontaneous calcified embolus of the cerebral arteries on a calcified mitral and aortic stenosis.

Radiol Case Rep 2022 Sep 14;17(9):2899-2901. Epub 2022 Jun 14.

Central Imaging Department, Ibn Rochd University Hospital, 1 quartier des hopitaux, Casablanca, Morocco.

We report a case of calcified mitral and aortic stenosis revealed by a reversible ischemic stroke. A 59-year-old male patient, with background of hypertension, kidney failure, diabetes, and dyslipidemia, presented with neither acute onset of right-sided hemiparesis without aphasia nor any loss of consciousness. Head computed tomography (CT) revealed multiple rounded and amorph calcified high-density calcifications within the distal segments of both sylvian and posterior cerebral arteries. Read More

View Article and Full-Text PDF
September 2022

Progression of aortic stenosis after an acute myocardial infarction.

Open Heart 2022 Jun;9(1)

Québec Heart and Lung Institute, Laval University, Québec City, Québec, Canada

Background: Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression. We thus compared AS progression after an acute MI and in patients with/without history of MI, and assessed post-MI pathobiological changes within the aortic valve leaflets in a sheep model. Read More

View Article and Full-Text PDF

The effect of stent and decalcification on mitral annular motion after aortic valve replacement.

J Card Surg 2022 Jun 21. Epub 2022 Jun 21.

Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.

Objective: The purpose of this study was to evaluate the changes in mitral annular motion after surgery in patients with aortic stenosis.

Methods: Patients receiving Edwards (Edwards) valves were included in the study. Echocardiographic findings were compared among the three treatments postoperatively, at discharge, and at 1 year after the surgery. Read More

View Article and Full-Text PDF

Staging of Valve Disease Based on the Extent of Cardiac Damage: Ready for the Guidelines?

JACC Cardiovasc Imaging 2022 Jun;15(6):971-973

Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA. Electronic address:

View Article and Full-Text PDF

Persistent right heart dilatation after percutaneous mitral balloon valvuloplasty: A weird coexistence of iatrogenic and congenital shunts.

Echocardiography 2022 Jun 8. Epub 2022 Jun 8.

Department of Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.

We present an interesting case of concomitant congenital anomalies with an iatrogenic defect. The female patient underwent a percutaneous mitral balloon valvuloplasty due to rheumatic mitral stenosis. Unfortunately, an iatrogenic atrial septal defect (ASD) transpired during the procedure. Read More

View Article and Full-Text PDF

Left Ventricular Diastolic Function: Comparison of Slow Coronary Flow Phenomenon and Left Ventricular Hypertrophy in the Absence of Obstructive Coronary Disease.

Cureus 2022 May 6;14(5):e24789. Epub 2022 May 6.

Cardiology Department, University Hospital 'St Ivan Rilski', Sofia, BGR.

Background An interplay of myocardial structural abnormalities and coronary arterial dysfunction underlies the worsening left ventricular compliance. The conventionally used angina drugs have demonstrated a beneficial effect on both angina and coronary flow in cases with microvascular dysfunction and non-obstructive coronary disease. Despite that, vasoactive therapy only partially affects diastolic function in this patient population. Read More

View Article and Full-Text PDF

Prevalence and Natural History of Mitral Annulus Calcification and Related Valve Dysfunction.

Mayo Clin Proc 2022 Jun;97(6):1094-1107

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN. Electronic address:

Objective: To evaluate the prevalence and natural history of mitral annulus calcification (MAC) and associated mitral valve dysfunction (MVD) in patients undergoing clinically indicated echocardiography.

Methods: A retrospective review was conducted of all adults who underwent echocardiography in 2015. Mitral valve dysfunction was defined as mitral regurgitation or mitral stenosis (MS) of moderate or greater severity. Read More

View Article and Full-Text PDF

Potential role of conventional and speckle-tracking echocardiography in the screening of structural and functional cardiac abnormalities in elderly individuals: Baseline echocardiographic findings from the LOOP study.

PLoS One 2022 3;17(6):e0269475. Epub 2022 Jun 3.

Department of Cardiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.

Background: Elderly individuals occupy an increasing part of the general population. Conventional and speckle-tracking transthoracic echocardiography may help guide risk stratification in these individuals. The purpose of this study was to evaluate the potential utility of conventional and speckle-tracking echocardiography in the screening of cardiac abnormalities in the elderly population. Read More

View Article and Full-Text PDF

CT in Transcatheter-delivered Treatment of Valvular Heart Disease.

Radiology 2022 Jul 31;304(1):4-17. Epub 2022 May 31.

From the Division of Cardiovascular Imaging, Department of Radiology and Radiological Science (P.N.R., U.J.S., J.R.B., T.E., A.V.S.), and Department of Cardiology (N.S.A., D.H.S., R.R.B.), Medical University of South Carolina, 25 Courtenay Dr, MSC 226, Charleston, SC 29425; Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland (P.N.R., M.D., C.K.); Department of Radiology for Providence Health Care, Vancouver Coastal Health, Vancouver, Canada (J.A.L.); Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland (D.D.); Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA), Ravenna, Italy (D.D.); Department of Diagnostic and Interventional Radiology, Universitätsklinikum Augsburg, Augsburg, Germany (F.S.); Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria (M.A.); Department of Measurement and Electronics, AGH University of Science and Technology, Krakow, Poland (A.Z.H.); Department of Cardiology, Medizinische Klinik I, RoMed Klinikum Rosenheim, Rosenheim, Germany (C.T.); Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany (M.R.); and Department of Radiology, Poznan University of Medical Sciences, Poznan, Poland (P.P.).

Minimally invasive strategies to treat valvular heart disease have emerged over the past 2 decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic stenosis, for example, has recently expanded from high- to low-risk patients and became an alternative treatment for those with prohibitive surgical risk. With the increase in transcatheter strategies, multimodality imaging, including echocardiography, CT, fluoroscopy, and cardiac MRI, are used. Read More

View Article and Full-Text PDF

Flow-Mediated Factors in the Pathogenesis of Hypoplastic Left Heart Syndrome.

J Cardiovasc Dev Dis 2022 May 12;9(5). Epub 2022 May 12.

Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON M5T 3H7, Canada.

Hypoplastic left heart syndrome (HLHS) is a life-threatening congenital heart disease that is characterized by severe underdevelopment of left heart structures. Currently, there is no cure, and affected individuals require surgical palliation or cardiac transplantation to survive. Despite these resource-intensive measures, only about half of individuals reach adulthood, often with significant comorbidities such as liver disease and neurodevelopmental disorders. Read More

View Article and Full-Text PDF

Papillary muscle avulsion following balloon mitral valvotomy evaluated with three-dimensional echocardiography.

BMC Surg 2022 May 21;22(1):199. Epub 2022 May 21.

Department of Cardiology, West China Hospital, Sichuan University, No. 37, Guoxue Street, Wuhou District, Chengdu, 610041, China.

Background: Percutaneous balloon mitral valvotomy is a common therapeutic approach for rheumatic mitral stenosis. Avulsion of the papillary muscle is a rare but serious complication of balloon mitral valvotomy. The papillary muscles are derived from the trabecular layer of the developing ventricular walls. Read More

View Article and Full-Text PDF

Hypereosinophilic syndrome presenting as acute ischemic stroke, myocardial infarction, and arterial involvement: A case report.

World J Clin Cases 2022 Apr;10(11):3547-3552

Department of Central Laboratory, Liaocheng People's Hospital, Liaocheng 252000, Shandong Province, China.

Background: Simultaneous cerebral and myocardial infarction with arterial involvement has not been reported in hypereosinophilic syndrome (HES). Here, we report a patient with HES that was also associated with acute ischemic stroke, myocardial infarction, and arterial involvement of the left common carotid artery, vertebral arteries, posterior cerebral artery, and coronary artery.

Case Summary: A 64-year-old male patient was admitted with headache and right lower extremity weakness. Read More

View Article and Full-Text PDF

Invasive Hemodynamic Predictors of Survival in Patients With Mitral Stenosis Secondary to Mitral Annular Calcification.

J Am Heart Assoc 2022 May 16;11(10):e023107. Epub 2022 May 16.

Department of Cardiovascular Diseases Mayo Clinic Rochester MN.

Background The aim of this study was to establish prognostic hemodynamic parameters in patients with mitral stenosis secondary to mitral annular calcification. Methods and Results A retrospective cohort of 105 patients undergoing transseptal catheterization for hemodynamic evaluation of mitral annular calcification-related mitral stenosis between 2004 and 2020 was studied. Mitral valve gradient (MVG) and mitral valve area (MVA; calculated by the Gorlin formula) were measured using direct left atrial and left ventricular pressures. Read More

View Article and Full-Text PDF

An Unusual Cause of Shortness of Breath: Pulmonary Vein Stenosis After Surgical Mitral Valve Replacement.

JACC Case Rep 2022 May 4;4(9):533-537. Epub 2022 May 4.

Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.

A 79-year-old man with prior bioprosthetic mitral valve replacement presented with progressive shortness of breath and was found to have right upper pulmonary vein stenosis and paravalvular leak diagnosed with the use of multimodal imaging. The patient underwent balloon angioplasty, stenting of the pulmonary vein, and paravalvular leak closure with ultimate resolution of symptoms. (). Read More

View Article and Full-Text PDF

Efficacy and Safety of Left Atrial Appendage Occlusion in Mild Mitral Stenosis Patients with High Bleeding Risk.

Int Heart J 2022 May 14;63(3):492-497. Epub 2022 May 14.

Department of Structural Heart Disease, The First Affiliated Hospital of Xi'an Jiaotong University.

Atrial fibrillation (AF) is highly prevalent in patients with mitral stenosis (MS), but the efficacy of left atrial appendage occlusion (LAAO) in these patients remains unclear.The aim of this study was to evaluate the efficacy and safety of LAAO in patients with MS complicated by AF at high risk of bleeding.We recruited patients from September 2015 to September 2018. Read More

View Article and Full-Text PDF

Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.

Catheter Cardiovasc Interv 2022 May;99(6):1817-1818

Department of Cardiology, Texas Heart Institute, Houston, Texas, USA.

View Article and Full-Text PDF

Association of Mild Valvular Lesions With Long-term Cardiovascular Outcomes Among Black Adults.

JAMA Netw Open 2022 May 2;5(5):e2211946. Epub 2022 May 2.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Importance: Little is known about the long-term outcomes of mild valvular lesions.

Objective: To examine the associations of 3 major types of valvular lesions (aortic stenosis, trace or mild aortic regurgitation, and trace or mild mitral regurgitation) with risk of cardiovascular mortality, coronary heart disease (CHD), stroke, heart failure, and atrial fibrillation.

Design, Setting, And Participants: This cohort study analyzed data from the ongoing Atherosclerosis Risk in Communities study and focused on Black participants in the Jackson, Mississippi, site who underwent echocardiography at visit 3 from 1993 to 1995. Read More

View Article and Full-Text PDF

Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation.

Am J Cardiol 2022 Jul 9;175:58-64. Epub 2022 May 9.

Heart Institute, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address:

Warfarin is the standard anticoagulation therapy for valvular atrial fibrillation (AF); however, new oral anticoagulants have emerged as an alternative. We compared the efficacy and safety of dabigatran with conventional treatment in AF associated with left-sided valvular heart disease (VHD), including mitral stenosis (MS). Patients with AF and left-sided VHD were randomly assigned to receive dabigatran or conventional treatment. Read More

View Article and Full-Text PDF

A Challenging Case of Mechanical Mitral Valve Obstruction.

Cureus 2022 Apr 8;14(4):e23945. Epub 2022 Apr 8.

Cardiology, Reading Hospital Tower Health System, Reading, USA.

Prosthetic valve thrombosis (PVT) is a frequent complication with a mechanical valve that presents with symptoms of heart failure or thromboembolic episodes. A 45-year-old lady with antiphospholipid syndrome (APS) complicated by a previous history of native mitral valve thrombus and mechanical mitral valve replacement maintained on warfarin presented with complaints of chest pain and shortness of breath (NYHA class 2). The initial lab showed a subtherapeutic international normalized ratio (INR) of 1. Read More

View Article and Full-Text PDF

Transcaval Versus Transaxillary TAVR in Contemporary Practice: A Propensity-Weighted Analysis.

JACC Cardiovasc Interv 2022 May;15(9):965-975

Emory Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: https://twitter.com/AdamGreenbaumMD.

Objectives: The aim of this study was to compare transcaval and transaxillary artery access for transcatheter aortic valve replacement (TAVR) at experienced medical centers in contemporary practice.

Background: There are no systematic comparisons of transcaval and transaxillary TAVR access routes.

Methods: Eight experienced centers contributed local data collected for the STS/ACC TVT Registry (Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry) between 2017 and 2020. Read More

View Article and Full-Text PDF

Anatomy of a Transcatheter Mitral Valve Service.

Front Cardiovasc Med 2022 15;9:862471. Epub 2022 Apr 15.

Cardiovascuar Directorate, Guy's and St Thomas' Hospitals, London, United Kingdom.

Transcatheter mitral therapies offer treatment options to selected patients who are unable to undergo open procedures due to prohibitive surgical risk. Data detailing the design and structure of transcatheter mitral services to ensure appropriate patient selection and tailored management strategies is lacking. We report our initial experience of developing and running a purpose-built transcatheter mitral service. Read More

View Article and Full-Text PDF

Extracorporeal Membrane Oxygenation-Supported Transcatheter Mitral Valve-in-Valve Replacement and Paravalvular Plugging for Critical Prosthetic Mitral Stenosis.

JACC Case Rep 2022 Apr 20;4(8):491-496. Epub 2022 Apr 20.

St Vincent's Hospital, Sydney, Australia.

We present the case of a patient with rapidly progressive bioprosthetic mitral valve stenosis in the setting of end-stage renal failure. Critical valve stenosis led to cardiogenic shock requiring full hemodynamic support. Emergent extracorporeal membrane oxygenation-supported transcatheter mitral valve-in-valve implantation was successfully undertaken as a life-saving measure with an excellent final result. Read More

View Article and Full-Text PDF

Approach to the Patient with a Murmur.

Med Clin North Am 2022 May 4;106(3):545-555. Epub 2022 Apr 4.

Department of Internal Medicine, UC Davis School of Medicine, 4150 V Street, Suite 2400, Sacramento, CA 95817, USA.

Patients with valvular heart disease may present with or without symptoms. A thorough cardiac physical examination can identify patients who require further evaluation and management. Although the utility of different cardiac findings varies widely, diastolic murmurs indicate important underlying valvular pathology requiring further investigation, typically with echocardiography. Read More

View Article and Full-Text PDF

[Early Structural Valve Deterioration of Bioprosthetic Mitral Valve in a Dialysis Patient].

Kyobu Geka 2022 May;75(5):335-339

Department of Cardiovascular Surgery, Northern Okinawa Medical Center, Nago, Japan.

Choice of prosthetic valve during valve replacement in dialysis patients is still controversial. There is a known risk of early structural valve deterioration of bioprosthesis in dialysis patients, whereas mechanical prosthesis is associated with a higher risk of bleeding and thrombotic events. A 68-year-old dialysis-dependent woman, who had undergone bioprosthetic mitral valve replacement at the age of 66, was admitted to our hospital because of general malaise and hypotension during dialysis. Read More

View Article and Full-Text PDF

Novel echocardiographic score to predict duct-dependency after percutaneous relief of critical pulmonary valve stenosis/atresia.

Echocardiography 2022 May 24;39(5):724-731. Epub 2022 Apr 24.

Paediatric Cardiology Unit, University of Campania "Luigi Vanvitelli", A.O.R.N. "Ospedali dei Colli", Naples, Italy.

Objectives: This study aimed to identify clinical, hemodynamic, or echocardiographic predictive features of persistent duct-dependency of pulmonary circulation (PDDPC) after effective percutaneous relief of pulmonary atresia with the intact ventricular septum (PA-IVS) or critical pulmonary stenosis (CPS).

Methods: From 2010 to 2021, 55 neonates with PA-IVS or CPS underwent percutaneous right ventricle (RV) decompression at our Institution. After successfully relief of critical obstruction, 27 patients (group I) showed PDDPC, whereas RV was able to support the pulmonary circulation in the remaining 28 patients (group II). Read More

View Article and Full-Text PDF

Clinical Outcomes of Mitral Valve Disease With Mitral Annular Calcification.

Am J Cardiol 2022 Jul 18;174:107-113. Epub 2022 Apr 18.

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota; Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address:

The prevalence of mitral valve disease with mitral annular calcification (MAC) and its clinical outcomes remain uncertain. This study sought to evaluate the prevalence of significant mitral disease due to MAC, and the impact of intervention on the clinical outcomes in these patients. All patients who underwent transthoracic echocardiography (TTE) between January 2014 and December 2015 in our health care system were reviewed and identified for having MAC with significant mitral valve disease (i. Read More

View Article and Full-Text PDF

Paravalvular Leak.

Methodist Debakey Cardiovasc J 2022 1;18(1):7-9. Epub 2022 Apr 1.

Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, US.

Despite improvements and advancements in surgical technique, paravalvular leaks (PVL) continue to present a challenge when caring for patients with prosthetic valve disease. Paravalvular leaks result from dehiscence of the surgical ring from the mitral annulus. Some theories suggest that uneven distribution of collagen fibers in the mitral annulus leaves the posterior mitral annulus without a well-formed fibrous structure, which may predispose it to recurrent mechanical injury that leads to PVL. Read More

View Article and Full-Text PDF

Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.

Catheter Cardiovasc Interv 2022 Jun 14;99(7):2113-2116. Epub 2022 Apr 14.

Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Disease, Fudan University, Shanghai, China.

Percutaneous balloon mitral valvuloplasty (PBMV) is not traditionally suitable for patients with mitral stenosis (MS) and left atrium (LA) thrombus. Moreover, PBMV cannot be performed in patients with LA thrombus not resolving after anti-coagulation treatment. Here we present a case of PBMV using a novel technique employing both a veno-arterial loop and neuro-embolic protection, in a patient with MS and LA thrombus resistant to warfarin therapy. Read More

View Article and Full-Text PDF

Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants.

Oscar M P Jolobe

Int J Cardiol 2022 Jul 11;358:87. Epub 2022 Apr 11.

British Medical Association, BMA House, Tavistock Square, London WC 1 H 9 JP, United Kingdom. Electronic address:

View Article and Full-Text PDF